bioRxivMicrobiology
Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice
F. Oladunni, J.-G. Park, P. Pino Tamayo, O. Gonzalez, A. Ahkter, A. Allue Guardia, A. Olmo-Fontanez, S. Gautam, A. Garcia Vilanova, C. Ye, K. Chiem, C. Headley, V. Dwivedi, L. Parodi, K. Alfson, H. Staples, A. Schami, J. Garcia, A. Whigham, R. N. Platt, M. Gazi, J. C. Martinez, C. Chuba, S. Earley, O. Rodriguez, , J. B. Torrelles
Abstract
ABSTRACTVaccine and antiviral development against SARS-CoV-2 infection or COVID-19 disease currently lacks a validated small animal model. Here, we show that transgenic mice expressing human angiotensin converting enzyme 2 (hACE2) by the human cytokeratin 18 promoter (K18 hACE2) represent a susceptible rodent model. K18 hACE2-transgenic mice succumbed to SARS-CoV-2 infection by day 6, with virus detected in lung airway epithelium and brain. K18 ACE2-transgenic mice produced a modest TH1/2/17 cytokine storm in the lung and spleen that peaked by day 2, and an extended chemokine storm that was detected in both lungs and brain. This chemokine storm was also detected in the brain at day 4. K18 hACE2-transgenic mice are, therefore, highly susceptible to SARS-CoV-2 infection and represent a suitable animal model for the study of viral pathogenesis, and for identification and characterization of vaccines (prophylactic) and antivirals (therapeutics) for SARS-CoV-2 infection and associated severe COVID-19 disease.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
Joseph W. Golden, Curtis R. Cline, … Jay W. Hooper·bioRxiv·Jul 9, 2020
- K18-hACE2 mice develop respiratory disease resembling severe COVID-19
C. K. Yinda, J. R. Port, … V. Munster·bioRxiv·Aug 11, 2020
- Characterization of low copy number human angiotensin-convertase 2 (hACE2)-transgenic mice as an improved model of SARS-CoV-2 infection
C. M. Bradshaw, T. Georgieva, … J. Z. Nikolich·bioRxiv·Aug 31, 2023
- Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
R. Rathnasinghe, S. Strohmeier, … M. B. Uccellini·Emerging Microbes & InfectionsPeer-reviewed·Jan 1, 2020
- Evaluation of K18-hACE2 mice as a model of SARS-CoV-2 infection
G. B. Moreau, S. L. Burgess, … B. J. Mann·bioRxiv·Jun 26, 2020
- The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus